Condition
De-escalation
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown2
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07498959Not ApplicableRecruiting
Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer
NCT03248258Completed
Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)
NCT04867330Not ApplicableUnknown
Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCC
NCT04012502Not ApplicableUnknown
De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese Populations
Showing all 4 trials